Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Sectra Ab LSE:0A0L London Ordinary Share SE0014609061 SECTRA ORD SHS CLASS B
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 335.50 345 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

Institut Bergonié among the first in France to implement full-scale digital pathology--improves care for cancer patients wit...

19/01/2021 7:56am

PR Newswire (US)


Sectra Ab (LSE:0A0L)
Historical Stock Chart


From Jul 2020 to Jul 2021

Click Here for more Sectra Ab Charts.

LINKÖPING, Sweden, Jan. 19, 2021 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received an order from Institut Bergonié for its digital pathology solution. It will be one of the first digital pathology installations for full-scale primary diagnostics in France. The solution will enable pathologists to review and collaborate around cases in a manner previously not possible using a microscope. It reduces variation and increases efficiency, thereby improving care for cancer patients.

"We have been looking for an intuitive solution that will allow our pathologists to quickly adapt and utilize all the benefits that come with the technology. It was also important to find a vendor with solid experience of similar installations. Sectra ticked all the boxes," says Dr. Gaëtan MacGrogan, Chief Pathologist at Institut Bergonié. 

The Institut Bergonié is a non-profit private hospital and offers dedicated inpatient and outpatient cancer treatment. It is part of UNICANCER, which is a national hospital network of 20 French Comprehensive Cancer Centres. 

"Institut Bergonié is at the forefront of fighting cancer. It is now taking yet another important step as one of the first hospitals in France to adopt a digital pathology workflow. We are really looking forward to working together to help Institut Bergonié reach its vision for cancer care," says Fabien Lozach, Managing Director of Sectra France. 

The solution will be integrated with the laboratory information system (LIS) at Institut Bergonié. Tight integration between Sectra's solution and the LIS will provide pathologists with a complete overview of patient history-in one application-and enable an efficient workflow based on, for example, sub-specialization and priority. The solution's vendor-neutral approach also provides freedom of choice in selecting a scanner vendor. 

The five-year contract was signed in December 2020. 

Sectra's digital pathology solution

Sectra's digital pathology solution includes digital tools that enable pathologists to make their diagnoses and carry out reporting with higher precision and less time spent per case. Using digital images of tissue samples rather than physical glass slides, pathologists can access and share current and historical images and information from anywhere and at any time. Digital access also facilitates second opinions, external reading resources and specialist consultations, in addition to enabling integrated diagnostics. It is a complete, vendor-neutral solution for primary diagnostics that includes storage solutions and an advanced review workstation.

Sectra's pathology solution is part of its enterprise imaging solution. It provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Read more about Sectra's enterprise imaging solution and why Sectra PACS is ranked "Best in KLAS" for seven consecutive years at medical.sectra.com.

About Sectra

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.

For further information, please contact:

Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27

Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/institut-bergonie-among-the-first-in-france-to-implement-full-scale-digital-pathology-improves-care-,c3255400

The following files are available for download:

https://news.cision.com/sectra/i/sectra-s-digital-pathology-solution,c2861524

Sectra's digital pathology solution

 

Copyright 2021 PR Newswire

1 Year Sectra Ab Chart

1 Year Sectra Ab Chart

1 Month Sectra Ab Chart

1 Month Sectra Ab Chart
ADVFN Advertorial
Your Recent History
LSE
0A0L
Sectra Ab
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210725 18:15:07